The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of BRAF and RAS mutations in radically resected patients (pts) with stage I-III melanoma: Preliminary results from a retrospective study.
 
Sonia Brugnara
No Relationships to Disclose
 
Mariacristina Sicher
No Relationships to Disclose
 
Salvatore Girlando
No Relationships to Disclose
 
Maria Elena Bonandini
No Relationships to Disclose
 
Mattia Barbareschi
No Relationships to Disclose
 
Michela Frisinghelli
No Relationships to Disclose
 
Daniela Mangiola
No Relationships to Disclose
 
Orazio Caffo
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen Oncology; Pfizer
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Medivation; Janssen; MSD Oncology
Speakers' Bureau - Astellas Pharma